Charles River/$CRL
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Charles River
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Ticker
$CRL
Sector
Primary listing
NYSE
Employees
19,400
Headquarters
Website
Charles River Metrics
BasicAdvanced
$7.6B
-
-$1.37
1.48
-
Price and volume
Market cap
$7.6B
Beta
1.48
52-week high
$217.00
52-week low
$91.86
Average daily volume
934K
Financial strength
Current ratio
1.36
Quick ratio
0.88
Long term debt to equity
81.952
Total debt to equity
82.039
Interest coverage (TTM)
4.99%
Profitability
EBITDA (TTM)
1,001.248
Gross margin (TTM)
35.03%
Net profit margin (TTM)
-1.66%
Operating margin (TTM)
14.41%
Effective tax rate (TTM)
-257.39%
Revenue per employee (TTM)
$210,000
Management effectiveness
Return on assets (TTM)
4.31%
Return on equity (TTM)
-1.81%
Valuation
Price to revenue (TTM)
1.941
Price to book
2.27
Price to tangible book (TTM)
-41.02
Price to free cash flow (TTM)
13.515
Free cash flow yield (TTM)
7.40%
Free cash flow per share (TTM)
11.435
Growth
Revenue change (TTM)
-1.21%
Earnings per share change (TTM)
-116.46%
3-year revenue growth (CAGR)
2.99%
10-year revenue growth (CAGR)
11.83%
3-year earnings per share growth (CAGR)
-45.74%
10-year earnings per share growth (CAGR)
-7.30%
What the Analysts think about Charles River
Analyst ratings (Buy, Hold, Sell) for Charles River stock.
Charles River Financial Performance
Revenues and expenses
Charles River Earnings Performance
Company profitability
Charles River News
AllArticlesVideos
Charles River Sees Limited Impact From NIH Cuts, Tariffs, Drug Pricing
Benzinga·2 weeks ago
Creightons shares fall 10% as cautious outlook tempers improved results
Proactive Investors·1 month ago
Charles River Laboratories Schedules Second-Quarter 2025 Earnings Release and Conference Call
Business Wire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Charles River stock?
Charles River (CRL) has a market cap of $7.6B as of August 22, 2025.
What is the P/E ratio for Charles River stock?
The price to earnings (P/E) ratio for Charles River (CRL) stock is 0 as of August 22, 2025.
Does Charles River stock pay dividends?
No, Charles River (CRL) stock does not pay dividends to its shareholders as of August 22, 2025.
When is the next Charles River dividend payment date?
Charles River (CRL) stock does not pay dividends to its shareholders.
What is the beta indicator for Charles River?
Charles River (CRL) has a beta rating of 1.48. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.